Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 101  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE Here 
  Search
 
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::Related articles
 ::  Article in PDF (385 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  Abstract
 :: Introduction
 ::  Materials and Me...
 :: Results
 :: Discussion
 :: Acknowledgments
 ::  References
 ::  Article Tables

 Article Access Statistics
    Viewed1892    
    Printed39    
    Emailed1    
    PDF Downloaded27    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


 


 
  Table of Contents     
ORIGINAL ARTICLE
Year : 2013  |  Volume : 59  |  Issue : 1  |  Page : 21-24

Minimally invasive parathyroidectomy under local anesthesia


1 Department of General Surgery, Internal Medicine Clinic, Konya Training and Research Hospital, Konya, Turkey
2 Department of Nuclear Medicine, Internal Medicine Clinic, Konya Training and Research Hospital, Konya, Turkey
3 Department of Endocrinology, Internal Medicine Clinic, Konya Training and Research Hospital, Konya, Turkey

Date of Submission25-Sep-2012
Date of Decision07-Nov-2012
Date of Acceptance15-Nov-2012
Date of Web Publication22-Mar-2013

Correspondence Address:
B SevinÁ
Department of General Surgery, Internal Medicine Clinic, Konya Training and Research Hospital, Konya
Turkey
Login to access the Email id


DOI: 10.4103/0022-3859.109485

PMID: 23525054

Get Permissions


 :: Abstract 

Background: More than 85% of primary hyperparathyroidism (PHPT) cases are due to solitary, benign parathyroid adenomas. Recently, the success rate of Tc99m sestamibi scintigraphy in localization has made minimally invasive parathyroidectomy (MIP) more prominent. MIP is as effective as conventional bilateral neck exploration. Moreover, it offers lower morbidity, cost effectiveness, and better cosmetics effects. Aim: We aimed to evaluate the success of MIP, which happens only under local anesthesia, in this study. Materials and Methods: Total of 63 patients were operated for PHPT, of which 54 had solitary adenoma. Five patients underwent bilateral neck exploration under general anesthesia for thyroid nodules or unlocalizated adenomas. A total of 49 patients underwent MIP under local anesthesia without any sedation. During MIP, gamma probe was used for all patients. The patients were followed for parathyroid functions. Results: The mean age of 49 patients with MIP (5 male, 44 female) was 59 years. The mean follow-up time was 16.4 (±10.1) months (range: 2-36 months). Of the 49 patients, 47 (96%) were totally cured. In 2 patients, the procedure was switched to conventional bilateral neck exploration. Temporary hypocalcaemia was noted in 4 patients. Conclusions: If the adenoma is localizated, MIP under only local anesthesia can be performed with a high success rate. Gamma probe-guided MIP under local anesthesia is an effective and safe method. It has the advantage of being minimally invasive and, therefore, it should be preferred over the conventional method.


Keywords: Gamma probe, local anesthesia, minimally invasive parathyroidectomy, primary hyperparathyroidism, parathyroid adenoma


How to cite this article:
Karahan ÷, Okus A, SevinÁ B, Eryilmaz M A, Ay S, «ayci M, Duran C. Minimally invasive parathyroidectomy under local anesthesia. J Postgrad Med 2013;59:21-4

How to cite this URL:
Karahan ÷, Okus A, SevinÁ B, Eryilmaz M A, Ay S, «ayci M, Duran C. Minimally invasive parathyroidectomy under local anesthesia. J Postgrad Med [serial online] 2013 [cited 2014 Oct 25];59:21-4. Available from: http://www.jpgmonline.com/text.asp?2013/59/1/21/109485



 :: Introduction Top


Primary hyperparathyroidism (PHPT) is caused by autonomous excess parathormone (PTH) secretion from one or more parathyroid glands. The incidence of PHPT increases after the age of 50 years, and is 2-4 times more common in females. PHPT may be caused by single adenoma (80-85%), parathyroid hyperplasia (10-15%), multiple adenomas (2-3%), and parathyroid carcinoma (1%). [1],[2],[3],[4] PHPT is the most common cause of hypercalcemia in outpatient clinics with an incidence of 25 in 100000, and it increases with age. [5]

Symptomatic PHPT can be accompanied by urinary stones, osteopenia, hypertension, peptic ulcer disease, fatigue, or mental status changes like somatic complaints. When calcium assays were not routinely followed, urinary system stones and osteodystrophic bone disease were common. However, with the introduction of easy and safe calcium and PTH assays, renal and osteodystrophic disease incidence has decreased to < 20%. Therefore, the diagnosis rate has increased 4-5 folds in recent years and most of the PHPT patients are diagnosed in asymptomatic state. [4],[5]

Conventional surgical approach to PHPT included exploration of bilateral neck areas and resection of the abnormal gland. However, minimally invasive procedure has become more used with the improvement of imaging technology, and with 80-85% of PHPT being single adenomas. After the first introduction of minimally invasive parathyroidectomy (MIP) by Norman and Chheda [6] in 1997, it became more common. MIP can be performed under general anesthesia, cervical blockage, or local anesthesia with sedation. In this study, we present our results of MIP in PHPT under local anesthesia without sedation.


 :: Materials and Methods Top


Study period, case definition and pre-op work up

Data of 63 patients who underwent surgery due to PHPT between November 2009 and March 2012 at Konya Training and Research Hospital was evaluated. PHPT was diagnosed by both an increase in serum calcium and PTH levels. Symptomatic and asymptomatic patients who met the criteria of 2002 National Institutes of Health (NIH) guidelines were selected for the surgery. [7] A surgeon, endocrinologist, and a nuclear medicine specialist were involved in assessment and evaluation of all the patients. Pre surgery, the patients were evaluated by ultrasonography (Siemens, Acuson Antares, Siemens Medical Solutions, USA) and Technetium (Tc) 99 m sestamibi dual-phase parathyroid scintigraphy (MIBI; Siemens E-cam Signature Dual Head, Siemens Medical Solutions Hoffman Estates, IL USA). Localization, extent of the adenoma, and the findings of nodular goiter were all recorded.

Surgical procedure

The patients with parathyroid hyperplasia underwent bilateral neck exploration and subtotal parathyroidectomy. The patients with surgical indications for nodular goiter, unlocalized adenomas despite the imaging studies and before neck surgery were candidates for exploration under general anesthesia. After preoperative detection of the adenoma, adenoma localization was assigned by 1 mCi Tc 99 sestamibi given through the antecubital vein, 1 hour before the surgery. Infiltration anesthesia with 5-8 ml of 2% prilocaine (Citanest®, AstraZeneca Türkiye Ýlaç Sanayi ve Ticaret), diluted with 0.9% isotonic sodium chloride solution, was performed. A skin incision of 2-3 cm was made on the area of the highest radioactivity count. Further anesthetic was administered with the cooperation of the patient. Adenoma was located with the guidance of a gamma probe (Crystal Gamma Probe, CXS-SG03, Germany), and it was totally excised after ligating the parathyroid vessels. Radioactivity count was measured at the rest tissue and the excised tissue. More than 50% decrease at the parathyroid bed was accepted as a successful procedure.

In case of any doubt in localization of the adenoma, MIP was planned similarly. When the adenoma could not be found, or the radioactivity count did not decrease to >50% (suspicion for a second adenoma), bilateral neck exploration under general anesthesia was done. No drainage tube was used for the MIP patients.

Post-op follow up

All MIP patents were discharged on the first day after the exclusion of hypercalcemia and the documentation of the decrease in PTH. Both intravenous or oral calcium and vitamin D were administered to the patients with hypercalcemia. The patients were discharged when the serum calcium levels were in the normal range. Follow up was done on days 30, 60 and 360. when the calcium and PTH levels were recorded.


 :: Results Top


Demographic data

There were 8 male and 55 female patients. The mean age was 51.8±1.4 years, mean calcium and PTH levels 10.9±0.15 mg/dl (reference: 8.4-10.2 mg/dl) and 473±86.6 pg/ml respectively (reference: 11-67 pg/ml) preoperatively, and 8.6±0.12 mg/dl and 113.8±31.8 pg/ml respectively at the postoperative first day. The mean follow-up time was 16.4±10.1 (2-36) months.

Disease details

In 54/63 (84.1%) patients, PHPT was due to parathyroid adenoma [Table 1]. In 50/54 patients with adenoma, the localization was detected by MIBI. The ability of the MIBI to detect adenomas was 93%; however, it was 47% for ultrasonography. In 54% of adenomas ( n=29), there was an accompanying nodular goiter. Among the patients with adenoma, 2 patients with accompanying nodular goiter, 2 patients with unlocalized adenomas, and 1 patient with double adenoma underwent bilateral neck exploration under general anesthesia. The 49 patients underwent MIP under local anesthesia [Table 2]. In 1 patient, the adenoma could not be found at the time of operation and in another with atypical localization (retroeosefageal), the procedure was switched to exploration under general anesthesia. The success rate of MIP was thus 96%. The localizations of the adenomas are given in [Table 3], and the most common localization was in the lower right (50%).
Table 1: Distribution of the cause of primary hyperparathyroidism

Click here to view
Table 2: Distribution of the surgical treatment methods

Click here to view
Table 3: Distribution of the adenoma localization

Click here to view


Safety and complications

Either temporary or persistent, there was no vocal cord paralysis after MIP. Temporary hypercalcemia was observed in 4 patients (6.3%). Recurrent hypercalcemia was observed in 2 patients at the follow-up visits. In one of those patients, a second adenoma was detected, and the patient was reoperated. In the other patient, there was no other adenoma detected by imaging studies and the patient is still being followed up.


 :: Discussion Top


The aim of the surgical treatment of PHPT is to remove the gland that causes abnormal calcium levels and to maintain normocalcemia. Moreover, in long term, it is to prevent bone mineral loss (or osteopenia) and systemic effects of hypercalcemia. [8]

Classical symptoms of PHPT such as bone pain, pathological fractures, urinary system stones, fatigue, and muscle weakness are related to hypercalcemia. The preferred treatment should be surgery in these symptomatic patients. However, because of the developments in diagnostic processes, PHPT cases are diagnosed earlier. When asymptomatic cases are evaluated, they have behavioral and mental disorders (e.g., fatigue, lethargy, depression, concentration disorders), which impair the quality of life. [1],[2],[3],[5] Moreover, hypercalcemia is related to increased mortality rate due to cardiovascular disorders such as left ventricular hypertrophy and arrhythmias. Several studies show the improvement of quality of life and decrease in the mortality rate by surgical treatment. [5],[9]

The standard surgical treatment was bilateral (four-glands) neck exploration under general anesthesia until 1990s. The success rate of this procedure is 95-97%, and hypercalcemia rate is 15%. [8] Tc 99 sestamibi scintigraphy has been used for parathyroid localization since 1989, and its sensitivity is reported as >85%. In this study, MIBI was found to be effective in localization of adenoma with a success rate of 93%. The radioactive sestamibi, used in MIBI, is kept by the mitochondria of oxiphilic cells of the parathyroid gland. Thyroid nodules can also keep sestamibi, and that may cause false positive results in patients with nodular goiter. On the other hand, small adenomas (less radioactivity is kept) and cystic adenomas (cannot be imaged) may cause false negative results. [5] Besides, multiple adenomas (multiglandular disease) may cause false negativity. [5],[10] Sensitivity of MIBI is higher, especially in adenomas >1 gr. [10] Ultrasonography has a lower sensitivity for adenoma localization; however, the combination of the two techniques has a sensitivity rate >95%. [11] In our study, the success rate of ultrasonography was found to be 47%, which may have been caused by the user experience. Ultrasonography is especially helpful in detection of nodular goiter and anatomical relations of the adenoma. [1],[5],[8],[11]

Parallel with the improvements of localization methods, minimally invasive parathyroidectomy that offers the chance of unilateral intervention, became more prominent. Preoperative imaging (mainly scintigraphic) techniques have changed the surgical strategy from wide traditional bilateral neck exploration to limited neck exploration. Developments during the past 10-15 years with regard to both the accuracy of preoperative localizing imaging techniques and intraoperative minimally invasive procedures in order to provide endocrinologists and endocrine surgeons with further information about the newly available diagnostic and therapeutic tools for use in PHPT patients with a solitary adenoma. [12] MIP has similar success rates with bilateral neck exploration. [13],[14] In adenoma-caused PHPT, MIP has a success rate >90%. [8],[15],[16],[17],[18],[19] However, MIP is required for preoperative localization studies. After localization of the adenoma, MIP can provide us smaller incision, better cosmetics, less tissue dissection, lower morbidity (hipoparathyroidism and recurrent laryngeal nerve injury), and shorter operation time and hospital stay. MIP can be applied as an outpatient surgery. [5],[8],[11],[14],[15],[18],[19]

Success of MIP can be enhanced with the guidance of gamma probe or the measurement of intact PTH levels. If the intact PTH levels decrease to >50%, the procedure is accepted as sufficient. If the decrease is <50%, another adenoma should be searched. Especially in multiple adenomas, intact PTH measurement is an important guide. [15] Several studies show the improvement of MIP by intact PTH measurement and the use of Gamma probe. [13],[14],[15],[20] Radio-guided MIP consists of low dose (1 mCi)) of Tc-sestamibi, given by intravenous injection, in the operating theatre a few minutes before surgery, thus allowing the radiation exposure dose to the patient and operating theatre personnel to be minimized. MIP using the Tc-sestamibi is a safe and effective treatment in PHPT patients with a high likelihood of a solitary parathyroid adenoma at preoperative imaging. [21] However, in specialized centers and with experience, the same results can be achieved without the use of those guidance. [11],[18],[22],[23],[24] In this study, compatible with the literature, we had a 96% success rate with gamma probe-assisted MIP. The use of gamma probe increases the experience in parathyroid surgery. [24] We did not measure intact PTH levels as it is an expensive method.

MIP is used for the excision of abnormal parathyroid gland with a smaller incision. MIP can be applied under general anesthesia, [11],[19] cervical blockage, [8] and sedation with local anesthesia. [15],[24],[25] However, there is only little information that it can be performed under local anesthesia without sedation. In this study, we have shown that MIP can be applied under only local anesthesia with the same success rate. Furthermore, this procedure does not have the risks and expense of general anesthesia. Especially for co-morbid patients who are risky for general anesthesia, [15] MIP can be easily performed under local anesthesia.

To conclude, MIP is a safe and effective method with a success rate of >95% for patients with single adenoma. A good preoperative evaluation and peroperative use of gamma probe improve the surgical success.


 :: Acknowledgments Top


The authors are grateful to Osman Doðru, Cemil Er, Bekir Gürocak, and Canan Sevinç for their contributions to the study.

 
 :: References Top

1.L. Michael Brunt. Nonthyroid Endocrine Surgery. Lippincott Williams and Willms, 2003.  Back to cited text no. 1
    
2.Aydýn Y, Akbaba G, Berker D. Endocrinological approach to asymtomatic primary hyperparathyrodism patients. Journal of Düzce Medical School 2009;11:43-6.  Back to cited text no. 2
    
3.Bilezikian JP, Rubin M, Silverberg SJ. Primary hyperparathyroidism: Diagnosis, evaluation and treatment. Curr Opin Endocrinol Diabetes 2004;11:345-52.  Back to cited text no. 3
    
4.Judson BL, Shaha AR. Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism. J Nucl Med 2008;49:1813-8.  Back to cited text no. 4
    
5.Sulýburk JW, Perrier ND. Primary hyperparathyroidism. Oncologist 2007;12:644-53.  Back to cited text no. 5
    
6.Norman J, Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997;122:998-1003.  Back to cited text no. 6
    
7.Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21 st century. J Clin Endocrinol Metab 2002;87:5353-61.  Back to cited text no. 7
    
8.Mekel M, Mahajna A, Ish-Shalom S, Barak M, Seqal E, Salih AA, et al. Minimally invasive surgery for treatment of hyperparathyroidism. Isr Med Assoc J 2005;7:323-7.  Back to cited text no. 8
    
9.Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodqson SF, O'Fallon WM, et al. Survival after the diagnosis of hyperparathyroidism. Am J Med 1998;104:115-22.  Back to cited text no. 9
    
10.Alabdulkarim Y, Nassif E. Sestamibi (99mTc) scan as a single localization modality in primary hyperparathyroidism and factors impacting its accuracy. Indian J Nucl Med 2010;25:6-9.  Back to cited text no. 10
[PUBMED]  Medknow Journal  
11.Haciyanli M, Genc H, Damburaci N, Oruk G, Tutuncuoglu P, Erdogan N. Minimally invasive focused parathyroidectomy without using intraoperative parathyroid hormone monitoring or gamma probe. J Postgrad Med 2009;55:242-6.  Back to cited text no. 11
[PUBMED]  Medknow Journal  
12.Rubello D, Gross MD, Mariani G, AL-Nahhas A. Scintigraphic techniques in primary hyperparathyroidism: From pre-operative localisation to intra-operative imaging. Eur J Nucl Med Mol Imaging 2007;34:926-33.  Back to cited text no. 12
    
13.Aspinall SR, Boase S, Malycha P. Long-term symptom relief from primary hyperparathyroidism following minimally invasive parathyroidectomy. World J Surg 2010;34:2223-7.  Back to cited text no. 13
    
14.Trolle W, Møller H, Bennedbaek FN, Nygaard B, Sørensen CH. Minimally invasive surgery for hyperparathyroidism. Ugeskr Laeger 2010;172:33-8.  Back to cited text no. 14
    
15.Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg 2000;231:732-42.  Back to cited text no. 15
    
16.Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, et al. Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring. Endocr J 2010;57:953-8.  Back to cited text no. 16
    
17.Atila K, Koçdor MA, Sevinç AÝ. Preoperative parathyroid localisation with sestamibi and minimal invasive parathyroidectomy: Our first results. Turk J Surg 2003;19:208-14.  Back to cited text no. 17
    
18.Jacobson SR, van Heerden JA, Farley DR, Grant CS, Thompson GB, Mullan BP, et al. Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormon monitoring or use of the gamma probe. Word J Surg 2004;28:1127-31.  Back to cited text no. 18
    
19.Pitale A, Andrabi SI, Dolan SJ, Russell CF. Minimally invasive parathyroid exploration for solitary adenoma. Initial experience with an open, 'short incision' approach. Ulster Med J 2008;77:115-8.  Back to cited text no. 19
    
20.Morris LF, Zanocco K, Ituarte PH, Ro K, Duh QY, Sturgeon C, et al. The value of intraoperative parathyroid hormone monitoring in localized primary hyperparathyroidism: A cost analysis. Ann Surg Oncol 2010;17:679-85.  Back to cited text no. 20
    
21.Rubello D, Mariani G, Al-Nahhas A, Pelizzo MR, Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS). Minimally invasive radio-guided parathyroidectomy: Long-term results with the 'low 99mTc-sestamibi protocol'. Nucl Med Commun 2006;27:709-13.  Back to cited text no. 21
    
22.Shaha AR, Patel SG, Singh B. Minimally invasive parathyroidectomy: The role of radio-guided surgery. Laryngoscope 2002;112:2166-9.  Back to cited text no. 22
    
23.Goldstein RE, Billheimer D, Martin WH, Richards K. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg 2003;237:722-30.  Back to cited text no. 23
    
24.Inabnet WB III, Kim CK, Haber RS, Lopchinsky RA. Radioguidance is not necessary during parathyroidectomy. Arch Surg 2002;137:967-70.  Back to cited text no. 24
    
25.Shindo ML, Rosenthal JM, Lee T. Minimally invasive parathyroidectomy using local anesthesia with intravenous sedation and targeted approaches. Otolaryngol Head Neck Surg 2008;138:381-7.  Back to cited text no. 25
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3]

This article has been cited by
1 The increasing role of minimal invasive radioguided parathyroidectomy for treating single parathyroid adenoma
Grassetto, G. and Rubello, D.
Journal of Postgraduate Medicine. 2013; 59(1): 1-3
[Pubmed]



 

Top
Print this article  Email this article
 
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Medknow